Johnson & Johnson (JNJ) is a diversified healthcare firm and one of the world’s most valuable companies. It is considered to be the world’s largest healthcare firm with divisions in pharmaceuticals, diagnostics, and medical devices. JNJ has drugs in immunology, neurology, oncology, cardiology, pulmonary, and metabolic diseases segments. The company also has a consumer product segment. The company’s scale, its vast product portfolio, and a strong brand are the key drivers of its long-term growth.
The long term monthly chart for JNJ shows a clear and consistent uptrend that has been in play since 2012. The price has consistently made higher highs and higher lows. However, in September and October of 2020, prices fell 15% and went below an important level at $140 which has acted as support and resistance. In November, however, prices went back above the $140 level and now look poised to retest the peaks of $155. A tight stop loss can be placed below the November candle low of $137.
Entered into our long term tracking portfolio today as follows. Entry point $143.33 . Stop loss $123.79 and short term to medium take profit set at $175.93 giving a profit of 33%.
On the video and images above you will see the reason this stock was selected.
You will see the image is of a monthly chart of the stock showing the long-term upwards trend formed over the years. You will also see the entry point and the where the stop loss is placed. For more information please watch the video given.
Once it is time to move the original stop loss up you will see an additional image.